Skip to main content
Clinical Trials/CTRI/2014/08/004924
CTRI/2014/08/004924CompletedPhase 2

Efficacy of Rewand chini (Rheum emodi) in the management of Primary dysmenorrhoea

ational Institute of Unani Medicine0 sites45 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
45

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Unmarried patients of primary dysmenorrhoea belongs to above age group with regular menstrual cycle were included in the study.

Exclusion Criteria

  • Patients with pelvic pathology, irregular cycles, systemic illness, allergic to NSAIDs, married women and mild dysmenorrhoea were excluded.

Investigators

Sponsor
ational Institute of Unani Medicine

Similar Trials